| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | Sep 3, 2024 | Quince Therapeutics, Inc. | CEO | Buy | 95.0 | +154,500 | 22.41% | ✗ | $107.4K |
| Aug 10, 2023 | Aug 11, 2023 | Quince Therapeutics, Inc. | CEO | Buy | 95.0 | +88,000 | 24.38% | ✗ | $110.9K |
| Aug 8, 2023 | Aug 9, 2023 | Quince Therapeutics, Inc. | CEO | Buy | 95.0 | +80,000 | 28.48% | ✗ | $99.2K |